Oruka Therapeutics, Inc.
ORKA
Acquisition of Pre-Merger Oruka On August 29, 2024 (the Merger Closing ), we completed our acquisition (the Merger ) of Oruka Therapeutics, Inc. ( Pre-Merger Oruka ) pursuant to an Agreement and Plan of Merger and Reorganization, dated as of April 3, 2024 (the Merger Agreement ). Following the transactions contemplated by the Merger Agreement, Pre-Merger Oruka merged with and into Atlas Merger …
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$153M
Op. Margin
–
ROIC
-17.64%
Cash Flow & Balance Sheet
FCF (TTM)
-$124M
Op. Cash Flow (TTM)
-$124M
Net Debt
-$917M
Net Cash Position
Cash & Equiv.
$920M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with ORKA
Held by ETFs
ORKA is in 63 US ETFs. The largest of them, with ORKA's weight in each:
Oruka Therapeutics (ORKA) in three numbers
Questions about Oruka Therapeutics
Is Oruka Therapeutics a high-quality business?
Oruka Therapeutics scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from SEC filings. Its best check is net debt at -$917M, and its weakest is return on capital at -17.6%. The Quality tab shows every check against its target.
Does Oruka Therapeutics (ORKA) pay a dividend?
No. Oruka Therapeutics (ORKA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 31 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 11 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in ORKA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ORKA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.